[Form 4] HEALTHSTREAM INC Insider Trading Activity
Rhea-AI Filing Summary
Kevin P. O'Hara, identified as an Executive Vice President and officer of HealthStream, filed a Form 4 reporting changes in his beneficial ownership of HSTM stock.
The filing shows a reported disposition of 17,137 shares of common stock (listed as "17,137 D" in the non-derivative section). It also reports the acquisition on 09/24/2025 of 2,586 restricted share units (RSUs) at $0 per unit. Each RSU converts to one share upon vesting and is held directly. The RSUs vest over four years contingent on continued service: 15% vests 09/24/2026, 20% vests 09/24/2027, 30% vests 09/24/2028, and 35% vests 09/24/2029.
Positive
- RSU grant of 2,586 units supports executive retention through a multi-year vesting schedule
- Clear vesting schedule defined: 15% (2026), 20% (2027), 30% (2028), 35% (2029)
Negative
- Reported disposal of 17,137 common shares is recorded without an accompanying price or explanation
- No price shown for the non-derivative disposal entry, limiting interpretability
Insights
TL;DR: Routine officer compensation and a reported share disposal; appears non-material to corporate control.
The Form 4 documents a standard equity compensation grant in the form of 2,586 RSUs with a multi-year service-based vesting schedule, which is typical for executive retention. The reported disposal of 17,137 common shares is recorded but the filing does not disclose price or reason for the disposal. From a governance perspective, these entries are consistent with routine insider transactions and do not by themselves indicate a change in control or governance strategy.
TL;DR: The RSU award is a service-contingent retention grant; vesting percentages and timeline are clearly specified.
The grant of 2,586 RSUs at zero purchase price is a standard equity award that aligns the executive with shareholder interests over four years via staged vesting of 15%, 20%, 30%, and 35%. The filing specifies direct ownership of the RSUs and confirms conversion to one share per unit on vesting. There is no disclosure of exercise or purchase price complexity given these are restricted share units.